The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 432 | 12,005 | SH | SOLE | 12,005 | 0 | 0 | ||
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 973 | 9,933 | SH | SOLE | 9,933 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 227 | 11,632 | SH | SOLE | 11,632 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 1,100 | 13,684 | SH | SOLE | 13,684 | 0 | 0 | ||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 510 | 33,641 | SH | SOLE | 33,641 | 0 | 0 | ||
AMGEN INC | COM | 031162100 | 294 | 1,518 | SH | SOLE | 1,518 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 447 | 9,770 | SH | SOLE | 9,770 | 0 | 0 | ||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 596 | 6,190 | SH | SOLE | 6,190 | 0 | 0 | ||
AUDENTES THERAPEUTICS INC | COM | 05070R104 | 487 | 17,339 | SH | SOLE | 17,339 | 0 | 0 | ||
BIO TECHNE CORP | COM | 09073M104 | 303 | 1,551 | SH | SOLE | 1,551 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 261 | 1,123 | SH | SOLE | 1,123 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 453 | 10,852 | SH | SOLE | 10,852 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 654 | 9,700 | SH | SOLE | 9,700 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 498 | 6,780 | SH | SOLE | 6,780 | 0 | 0 | ||
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 1,673 | 33,000 | SH | SOLE | 33,000 | 0 | 0 | ||
ISHARES TR | NASDAQ BIOTECH | 464287556 | 8,458 | 85,000 | SH | Call | SOLE | 85,000 | 0 | 0 | |
CELGENE CORP | COM | 151020104 | 559 | 5,625 | SH | SOLE | 5,625 | 0 | 0 | ||
CHARLES RIV LABS INTL INC | COM | 159864107 | 280 | 2,112 | SH | SOLE | 2,112 | 0 | 0 | ||
CHECKPOINT THERAPEUTICS INC | COM | 162828107 | 281 | 112,760 | SH | SOLE | 112,760 | 0 | 0 | ||
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 542 | 13,214 | SH | SOLE | 13,214 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 632 | 18,631 | SH | SOLE | 18,631 | 0 | 0 | ||
DIREXION SHS ETF TR | SP BIOTCH BL NEW | 25490K323 | 3,086 | 99,855 | SH | SOLE | 99,855 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 520 | 50,378 | SH | SOLE | 50,378 | 0 | 0 | ||
EXACT SCIENCES CORP | COM | 30063P105 | 771 | 8,534 | SH | SOLE | 8,534 | 0 | 0 | ||
EXELIXIS INC | COM | 30161Q104 | 232 | 13,132 | SH | SOLE | 13,132 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 212 | 5,742 | SH | SOLE | 5,742 | 0 | 0 | ||
FORTRESS BIOTECH INC | COM | 34960Q109 | 865 | 613,551 | SH | SOLE | 613,551 | 0 | 0 | ||
G1 THERAPEUTICS INC | COM | 3621LQ109 | 475 | 20,844 | SH | SOLE | 20,844 | 0 | 0 | ||
GILEAD SCIENCES INC | COM | 375558103 | 259 | 4,082 | SH | SOLE | 4,082 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 460 | 9,479 | SH | SOLE | 9,479 | 0 | 0 | ||
GRIFOLS S A | SP ADR REP B NVT | 398438408 | 264 | 13,196 | SH | SOLE | 13,196 | 0 | 0 | ||
GW PHARMACEUTICALS PLC | ADS | 36197T103 | 423 | 3,674 | SH | SOLE | 3,674 | 0 | 0 | ||
ILLUMINA INC | COM | 452327109 | 1,436 | 4,721 | SH | SOLE | 4,721 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 791 | 10,659 | SH | SOLE | 10,659 | 0 | 0 | ||
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 380 | 28,490 | SH | SOLE | 28,490 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 261 | 3,926 | SH | SOLE | 3,926 | 0 | 0 | ||
IONIS PHARMACEUTICALS INC | COM | 462222100 | 1,206 | 20,124 | SH | SOLE | 20,124 | 0 | 0 | ||
IQVIA HLDGS INC | COM | 46266C105 | 297 | 1,985 | SH | SOLE | 1,985 | 0 | 0 | ||
ISHARES TR | NASDAQ BIOTECH | 464287556 | 12,438 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
LIGAND PHARMACEUTICALS INC | COM NEW | 53220K504 | 242 | 2,428 | SH | SOLE | 2,428 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 384 | 30,075 | SH | SOLE | 30,075 | 0 | 0 | ||
METTLER TOLEDO INTERNATIONAL | COM | 592688105 | 2,279 | 3,235 | SH | SOLE | 3,235 | 0 | 0 | ||
NEKTAR THERAPEUTICS | COM | 640268108 | 235 | 12,927 | SH | SOLE | 12,927 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 282 | 3,127 | SH | SOLE | 3,127 | 0 | 0 | ||
PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 798 | 138,461 | SH | SOLE | 138,461 | 0 | 0 | ||
QIAGEN NV | SHS NEW | N72482123 | 951 | 28,858 | SH | SOLE | 28,858 | 0 | 0 | ||
RECRO PHARMA INC | COM | 75629F109 | 126 | 11,353 | SH | SOLE | 11,353 | 0 | 0 | ||
REGENERON PHARMACEUTICALS | COM | 75886F107 | 677 | 2,439 | SH | SOLE | 2,439 | 0 | 0 | ||
SEATTLE GENETICS INC | COM | 812578102 | 1,539 | 18,020 | SH | SOLE | 18,020 | 0 | 0 | ||
SPARK THERAPEUTICS INC | COM | 84652J103 | 941 | 9,699 | SH | SOLE | 9,699 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 217 | 5,064 | SH | SOLE | 5,064 | 0 | 0 | ||
UNIQURE NV | SHS | N90064101 | 560 | 14,215 | SH | SOLE | 14,215 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 279 | 3,498 | SH | SOLE | 3,498 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 1,403 | 8,279 | SH | SOLE | 8,279 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 389 | 9,725 | SH | SOLE | 9,725 | 0 | 0 |